MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") is pleased to note the attached three news releases by MediPharm Labs Inc ("MediPharm") providing the details of three customer contracts signed over the past month or so and ahead of its listing on the TSX Venture Exchange ("TSX-V") expected later this month.

MMJ's CEO Jason Conroy said that "We are delighted to see the momentum building for MediPharm ahead of its listing on the TSX-V."

MMJ owns approximately 6.9% of MediPharm.

To view the news releases, please visit:
http://abnnewswire.net/lnk/40E584H4


About MMJ PhytoTech Ltd

MMJ PhytoTech Limited (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/

      

Contact

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjphytotech.com.au



Link: MediPharm signs customer contracts ahead of TSX-V listing



Related Companies

MMJ PhytoTech Ltd
  


Related Industry Topics:
Food & Beverage Medical Equipment Drugs & OTC Ag Biotechnology Consumers General Health & Pharm General